n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Asensio, FJ | 1 |
| Hurtado, O | 1 |
| Burguete, MC | 1 |
| Moro, MA | 1 |
| Salom, JB | 1 |
| Lizasoain, I | 1 |
| Torregrosa, G | 1 |
| Leza, JC | 1 |
| Alborch, E | 1 |
| Castillo, J | 1 |
| Knowles, RG | 1 |
| Lorenzo, P | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Topics: Adenosine Triphosphate; Amidines; Amino Acid Transport System X-AG; Animals; Benzylamines; Brain; Ce | 2005 |